Simplex Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-38
Closed -$86K 8435
2019
Q4
$86K Buy
38
+34
+850% +$485 ﹤0.01% 4669
2019
Q3
$5K Sell
4
-15
-79% -$220 ﹤0.01% 6638
2019
Q2
$25K Buy
19
+18
+1,800% +$272 ﹤0.01% 5451
2019
Q1
$2K Sell
1
-4
-80% -$60 ﹤0.01% 6828
2018
Q4
$6K Sell
5
-12
-71% -$211 ﹤0.01% 6161
2018
Q3
$37K Sell
17
-25
-60% -$760 ﹤0.01% 5453
2018
Q2
$178K Sell
42
-56
-57% -$2.56K ﹤0.01% 3632
2018
Q1
$112K Buy
98
+73
+292% +$5.17K ﹤0.01% 1725
2017
Q4
$8K Sell
25
-38
-60% -$3.14K ﹤0.01% 4132
2017
Q3
$48K Sell
63
-13
-17% -$997 ﹤0.01% 2346
2017
Q2
$27K Buy
76
+48
+171% +$5.94K ﹤0.01% 3007
2017
Q1
$199K Sell
28
-95
-77% -$13.6K 0.01% 1207
2016
Q4
$17K Buy
123
+67
+120% +$7.55K ﹤0.01% 3201
2016
Q3
$27K Sell
56
-120
-68% -$11.9K ﹤0.01% 2678
2016
Q2
$27K Buy
176
+149
+552% +$18.5K ﹤0.01% 2640
2016
Q1
$35K Sell
27
-4
-13% -$811 ﹤0.01% 2288
2015
Q4
$98K Sell
31
-37
-54% -$12K 0.01% 1382
2015
Q3
$125K Buy
68
+29
+74% +$12.7K 0.01% 1245
2015
Q2
$275K Buy
39
+1
+3% +$425 0.02% 641
2015
Q1
$531K Buy
38
+13
+52% +$5.04K 0.06% 313
2014
Q4
$272K Buy
+25
New +$7.44K 0.03% 465

Other funds holding LUMO

Simplex Trading's LUMO Position: Q4 2019 in Review

Simplex Trading sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2019, closing a stake of 3,002 shares — an estimated $42.8K sold.

Simplex Trading first reported a position in LUMO in Q4 2014 and held it in 10 quarters. The position peaked at $1.54M in Q1 2017. 64 funds tracked by Wall St. Rank hold LUMO as of Q4 2019.

  • Simplex Trading reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Simplex Trading sold 3,002 Lumos Pharma, Inc. Common Stock shares in Q4 2019, an estimated $42.8K.
  • Simplex Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 10 quarters.
  • Simplex Trading's Lumos Pharma, Inc. Common Stock position peaked at $1.54M in Q1 2017.
  • 64 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2019.

Based on Simplex Trading's 13F filing for Q4 2019, filed 5 Feb 2020.